We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URA icon
4001
Global X Uranium ETF
URA
$5.74B
$9.88K ﹤0.01%
+226
New +$11.4K
MASS icon
4002
908 Devices
MASS
$473M
$9.87K ﹤0.01%
1,134
-3,006
-73% -$23.1K
HAYW icon
4003
Hayward Holdings
HAYW
$2.68B
$9.85K ﹤0.01%
569
-2,165
-79% -$31.6K
PROK icon
4004
ProKidney
PROK
$334M
$9.84K ﹤0.01%
4,822
-15,617
-76% -$28.6K
AP icon
4005
Ampco-Pittsburgh
AP
$178M
$9.84K ﹤0.01%
1,137
+996
+706% +$10.1K
SABS icon
4006
SAB Biotherapeutics
SABS
$299M
$9.83K ﹤0.01%
2,520
-749
-23% -$2.79K
HVAC
4007
AdvisorShares HVAC and Industrials ETF
HVAC
$14.2M
$9.83K ﹤0.01%
+232
New +$9.23K
GAME icon
4008
GameSquare
GAME
$39.8M
$9.82K ﹤0.01%
+3,107
New +$10.6K
OLOX
4009
Olenox Industries
OLOX
$1.44M
$9.81K ﹤0.01%
1,794
+1,120
+166% +$6.88K
MBRX icon
4010
Moleculin Biotech
MBRX
$12.3M
$9.8K ﹤0.01%
3,514
+1,679
+91% +$4.29K
ACIU icon
4011
AC Immune
ACIU
$251M
$9.76K ﹤0.01%
4,101
-2,908
-41% -$8.01K
SCM icon
4012
Stellus Capital Investment Corp
SCM
$218M
$9.75K ﹤0.01%
1,158
+583
+101% +$5.35K
NXE icon
4013
NexGen Energy
NXE
$6.16B
$9.74K ﹤0.01%
1,037
-7,797
-88% -$88.6K
CHKP icon
4014
Check Point Software Technologies
CHKP
$13.4B
$9.73K ﹤0.01%
74
+63
+573% +$8.19K
CVRX icon
4015
CVRx
CVRX
$71.9M
$9.72K ﹤0.01%
1,892
+686
+57% +$4.43K
SPTM icon
4016
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.2B
$9.71K ﹤0.01%
107
-4,879
-98% -$429K
ARCO icon
4017
Arcos Dorados Holdings
ARCO
$1.53B
$9.7K ﹤0.01%
1,203
+1,004
+505% +$8.67K
CRD.B icon
4018
Crawford & Co Class B
CRD.B
$563M
$9.69K ﹤0.01%
+929
New +$9.36K
ARLP icon
4019
Alliance Resource Partners
ARLP
$3.24B
$9.66K ﹤0.01%
+403
New +$10.2K
KEQU icon
4020
Kewaunee Scientific
KEQU
$98.5M
$9.66K ﹤0.01%
272
+213
+361% +$7.9K
ICVT icon
4021
iShares Convertible Bond ETF
ICVT
$7.96B
$9.62K ﹤0.01%
+79
New +$9.16K
POCI icon
4022
Precision Optics
POCI
$50.7M
$9.57K ﹤0.01%
1,877
+1,220
+186% +$5.94K
IGIB icon
4023
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$9.52K ﹤0.01%
+179
New +$9.51K
ARTL icon
4024
Artelo Biosciences
ARTL
$2.49M
$9.45K ﹤0.01%
937
+623
+198% +$16K
ONL
4025
Orion Office REIT
ONL
$143M
$9.45K ﹤0.01%
3,269
+2,623
+406% +$7.18K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.